Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

42.29USD
4:00pm EDT
Change (% chg)

$-0.44 (-1.03%)
Prev Close
$42.73
Open
$42.87
Day's High
$42.87
Day's Low
$41.99
Volume
148,721
Avg. Vol
113,377
52-wk High
$46.81
52-wk Low
$26.17

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $1,576.04
Shares Outstanding(Mil.): 36.88
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 111.69 11.65 15.73
EPS (TTM): 0.38 -- --
ROI: 6.43 -10.12 -8.37
ROE: 8.59 -9.92 -7.93

BRIEF-Repligen prices public offering of shares of common stock

* Repligen Corporation prices public offering of shares of common stock

Jun 27 2017

BRIEF-REPLIGEN CORP ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

* REPLIGEN CORPORATION ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

Jun 26 2017

BRIEF-Repligen and Spectrum to join forces

* Repligen Corp - deal expected to be accretive to repligen earnings per share in fiscal 2018

Jun 23 2017

BRIEF-Repligen posts Q4 adj. earnings per share $0.08

* Repligen reports fourth quarter 2016 financial results, provides guidance for 2017

Feb 22 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $131.88 -1.13
Novartis AG (NOVN.S) CHF79.80 +0.25
Roche Holding Ltd. (ROG.S) CHF242.10 -0.50
Roche Holding Ltd. (RO.S) CHF244.90 +1.20
Merck & Co., Inc. (MRK.N) $62.36 -0.21
Sanofi SA (SASY.PA) €82.67 +0.76
Amgen, Inc. (AMGN.OQ) $180.89 -0.17
Gilead Sciences, Inc. (GILD.OQ) $73.74 -0.65
Incyte Corporation (INCY.OQ) $133.56 -4.71

Earnings vs. Estimates